Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome-Mediated Mechanism

J Am Heart Assoc. 2020 Mar 17;9(6):e014120. doi: 10.1161/JAHA.119.014120. Epub 2020 Mar 15.

Abstract

Background Epidemiological studies have suggested an association between Helicobacter pylori (H pylori) infection and atherosclerosis through undefined mechanisms. Endothelial dysfunction is critical to the development of atherosclerosis and related cardiovascular diseases. The present study was designed to test the hypothesis that H pylori infection impaires endothelial function through exosome-mediated mechanisms. Methods and Results Young male and female patients (18-35 years old) with and without H pylori infection were recruited to minimize the chance of potential risk factors for endothelial dysfunction for the study. Endothelium-dependent flow-mediated vasodilatation of the brachial artery was evaluated in the patients and control subjects. Mouse infection models with CagA+H pylori from a gastric ulcer patient were created to determine if H pylori infection-induced endothelial dysfunction could be reproduced in animal models. H pylori infection significantly decreased endothelium-dependent flow-mediated vasodilatation in young patients and significantly attenuated acetylcholine-induced endothelium-dependent aortic relaxation without change in nitroglycerin-induced endothelium-independent vascular relaxation in mice. H pylori eradication significantly improved endothelium-dependent vasodilation in both patients and mice with H pylori infection. Exosomes from conditioned media of human gastric epithelial cells cultured with CagA+H pylori or serum exosomes from patients and mice with H pylori infection significantly decreased endothelial functions with decreased migration, tube formation, and proliferation in vitro. Inhibition of exosome secretion with GW4869 effectively preserved endothelial function in mice with H pylori infection. Conclusions H pylori infection impaired endothelial function in patients and mice through exosome-medicated mechanisms. The findings indicated that H pylori infection might be a novel risk factor for cardiovascular diseases.

Keywords: Helicobacter pylori; cardiovascular risk factor; endothelial dysfunction; exosomes.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aniline Compounds / pharmacology
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antigens, Bacterial / metabolism
  • Bacterial Proteins / metabolism
  • Benzylidene Compounds / pharmacology
  • Brachial Artery / metabolism
  • Brachial Artery / microbiology*
  • Brachial Artery / physiopathology
  • Case-Control Studies
  • Cell Line
  • Cell Movement
  • Cell Proliferation
  • China
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / microbiology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / microbiology*
  • Endothelium, Vascular / physiopathology
  • Exosomes / drug effects
  • Exosomes / metabolism
  • Exosomes / microbiology*
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / metabolism
  • Helicobacter Infections / microbiology*
  • Helicobacter Infections / physiopathology
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / metabolism
  • Helicobacter pylori / pathogenicity*
  • Host-Pathogen Interactions
  • Humans
  • Male
  • Mice, Inbred C57BL
  • Missouri
  • Neovascularization, Physiologic
  • Vasodilation* / drug effects
  • Young Adult

Substances

  • Aniline Compounds
  • Anti-Bacterial Agents
  • Antigens, Bacterial
  • Bacterial Proteins
  • Benzylidene Compounds
  • GW 4869
  • Gastrointestinal Agents
  • cagA protein, Helicobacter pylori